254 related articles for article (PubMed ID: 30793542)
1. AMH and INSL3 in testicular and extragonadal pathophysiology: what do we know?
Sansone A; Kliesch S; Isidori AM; Schlatt S
Andrology; 2019 Mar; 7(2):131-138. PubMed ID: 30793542
[TBL] [Abstract][Full Text] [Related]
2. Anti-Müllerian hormone, testosterone, and insulin-like peptide 3 as biomarkers of Sertoli and Leydig cell function during deslorelin-induced testicular downregulation in the dog.
Balogh O; Somoskői B; Kollár E; Kowalewski MP; Gram A; Reichler IM; Klein R; Kawate N; Mester L; Walter B; Müller L
Theriogenology; 2021 Nov; 175():100-110. PubMed ID: 34534687
[TBL] [Abstract][Full Text] [Related]
3. Male hypogonadism: an extended classification based on a developmental, endocrine physiology-based approach.
Rey RA; Grinspon RP; Gottlieb S; Pasqualini T; Knoblovits P; Aszpis S; Pacenza N; Stewart Usher J; Bergadá I; Campo SM
Andrology; 2013 Jan; 1(1):3-16. PubMed ID: 23258624
[TBL] [Abstract][Full Text] [Related]
4. Serum concentrations and testicular expressions of insulin-like peptide 3 and Anti-Müllerian hormone in normal and cryptorchid male horses.
Tsogtgerel M; Komyo N; Murase H; Hannan MA; Watanabe K; Ohtaki T; Tsumagari S; Kawate N; Nambo Y
Theriogenology; 2020 Sep; 154():135-142. PubMed ID: 32645589
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of insulin-like factor 3, anti-Mullerian hormone, inhibin B, and testosterone during pubertal transition in healthy boys: a longitudinal pilot study.
Johansen ML; Anand-Ivell R; Mouritsen A; Hagen CP; Mieritz MG; Søeborg T; Johannsen TH; Main KM; Andersson AM; Ivell R; Juul A
Reproduction; 2014; 147(4):529-35. PubMed ID: 24459206
[TBL] [Abstract][Full Text] [Related]
6. Anti-Müllerian hormone, testicular descent and cryptorchidism.
Rey RA; Grinspon RP
Front Endocrinol (Lausanne); 2024; 15():1361032. PubMed ID: 38501100
[TBL] [Abstract][Full Text] [Related]
7. Testicular anti-Müllerian hormone: clinical applications in DSD.
Josso N; Rey R; Picard JY
Semin Reprod Med; 2012 Oct; 30(5):364-73. PubMed ID: 23044872
[TBL] [Abstract][Full Text] [Related]
8. INSL3: A Marker of Leydig Cell Function and Testis-Bone-Skeletal Muscle Network.
Facondo P; Delbarba A; Maffezzoni F; Cappelli C; Ferlin A
Protein Pept Lett; 2020; 27(12):1246-1252. PubMed ID: 32981493
[TBL] [Abstract][Full Text] [Related]
9. INSL3 as a biomarker of Leydig cell functionality.
Ivell R; Wade JD; Anand-Ivell R
Biol Reprod; 2013 Jun; 88(6):147. PubMed ID: 23595905
[TBL] [Abstract][Full Text] [Related]
10. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism.
Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R
J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161
[TBL] [Abstract][Full Text] [Related]
11. An
Arato I; Luca G; Mancuso F; Bellucci C; Lilli C; Calvitti M; Hansen BC; Milardi D; Grande G; Calafiore R
Asian J Androl; 2018; 20(2):160-165. PubMed ID: 29148520
[TBL] [Abstract][Full Text] [Related]
12. The prepubertal testis: biomarkers and functions.
Valeri C; Schteingart HF; Rey RA
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):224-33. PubMed ID: 23549308
[TBL] [Abstract][Full Text] [Related]
13. Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression during postnatal testis development and in the adult testis of the rat.
Baarends WM; Hoogerbrugge JW; Post M; Visser JA; De Rooij DG; Parvinen M; Themmen AP; Grootegoed JA
Endocrinology; 1995 Dec; 136(12):5614-22. PubMed ID: 7588316
[TBL] [Abstract][Full Text] [Related]
14. Human testicular insulin-like factor 3: in relation to development, reproductive hormones and andrological disorders.
Bay K; Andersson AM
Int J Androl; 2011 Apr; 34(2):97-109. PubMed ID: 20550598
[TBL] [Abstract][Full Text] [Related]
15. Congenital hypogonadotropic hypogonadism and Kallmann syndrome as models for studying hormonal regulation of human testicular endocrine functions.
Trabado S; Lamothe S; Maione L; Bouvattier C; Sarfati J; Brailly-Tabard S; Young J
Ann Endocrinol (Paris); 2014 May; 75(2):79-87. PubMed ID: 24815726
[TBL] [Abstract][Full Text] [Related]
16. Hypogonadotropic hypogonadism as a model of post-natal testicular anti-Müllerian hormone secretion in humans.
Young J; Rey R; Schaison G; Chanson P
Mol Cell Endocrinol; 2003 Dec; 211(1-2):51-4. PubMed ID: 14656476
[TBL] [Abstract][Full Text] [Related]
17. Normal insulin-like peptide-3 levels despite low testosterone in adult males with Prader-Willi syndrome: variations in Leydig cell function from infancy through adulthood.
Hirsch HJ; Eldar-Geva T; Gross-Tsur V; Benarroch F; Roger M; Lahlou N
J Clin Endocrinol Metab; 2013 Jan; 98(1):E135-43. PubMed ID: 23150680
[TBL] [Abstract][Full Text] [Related]
18. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism.
Grinspon RP; Rey RA
Horm Res Paediatr; 2010; 73(2):81-92. PubMed ID: 20190544
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of male hypogonadism in childhood and adolescence.
Rey RA
Adv Lab Med; 2020 Jun; 1(2):20200024. PubMed ID: 37363780
[TBL] [Abstract][Full Text] [Related]
20. Spreading the clinical window for diagnosing fetal-onset hypogonadism in boys.
Grinspon RP; Loreti N; Braslavsky D; Valeri C; Schteingart H; Ballerini MG; Bedecarrás P; Ambao V; Gottlieb S; Ropelato MG; Bergadá I; Campo SM; Rey RA
Front Endocrinol (Lausanne); 2014; 5():51. PubMed ID: 24847309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
